Atossa Therapeutics Inc.

NASDAQ: ATOS · Real-Time Price · USD
0.78
-0.00 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
0.80
2.34%
After-hours: Aug 15, 2025, 07:37 PM EDT

Atossa Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
4K 4K 4K 4K 4K 5K 14K 3K 3K 3K 2K 2K 2K 2K 1.74K 6.22K 5.79K 9.26K
Gross Profit
-4K -4K -4K -4K -4K -5K 4K -3K -3K -3K -2K -2K -2K -2K -1.74K -6.22K -5.79K -9.26K
Operating Income
-9.04M -7.41M -7.15M -6.38M -7.11M -6.98M -9.02M -7.47M -7.79M -7.1M -8.14M -8.21M -6.59M -4.75M -4.83M -5.16M -7M -3.53M
Interest Income
645K 720K 837K 1M 1.07M 1.14M 1.24M 1.27M 983K 850K 877K 194K 11K 1K n/a n/a n/a n/a
Pretax Income
-8.42M -6.72M -6.35M -7.23M -6.05M -5.88M -7.75M -6.23M -9.83M -6.28M -7.49M -8.01M -6.67M -4.79M -4.83M -5.2M -7.04M -3.54M
Net Income
-8.42M -6.72M -6.35M -7.23M -6.05M -5.88M -7.75M -6.23M -9.83M -5.46M -6.84M -7.82M -6.75M -4.83M -4.83M -5.2M -7.04M -3.54M
Selling & General & Admin
3.54M 3.26M 3.75M 2.97M 3.55M 3.23M 3.35M 3M 4.09M 3.59M 3.15M 3.04M 3.16M 3.25M 3M 2.95M 3.21M 2.15M
Research & Development
5.5M 4.16M 3.4M 3.41M 3.55M 3.75M 5.65M 4.47M 3.71M 3.51M 4.99M 5.16M 3.43M 1.5M 1.83M 2.21M 3.8M 1.38M
Other Expenses
n/a n/a -4K n/a n/a n/a n/a n/a -30K -33K n/a n/a n/a -39K -3.63K -38.55K -35.48K -7.34K
Operating Expenses
9.04M 7.41M 7.15M 6.38M 7.11M 6.97M 9.01M 7.47M 7.79M 7.1M 8.14M 8.21M 6.59M 4.75M 4.83M 5.16M 7M 3.53M
Interest Expense
n/a n/a n/a n/a n/a n/a 820K n/a n/a n/a n/a n/a n/a n/a 3.63K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -5K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.04M 7.41M 7.15M 6.38M 7.11M 6.98M 9.02M 7.47M 7.79M 7.1M 8.14M 8.21M 6.59M 4.75M 4.83M 5.16M 7M 3.53M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -820K -647K -194K 77K 39K 3.63K 38.55K 35.48K 7.34K
Shares Outstanding (Basic)
129.17M 129.17M 126.62M 125.77M 125.73M 125.32M 125.3M 125.79M 126.62M 126.62M 126.62M 126.62M 126.62M 126.62M 126.54M 126.54M 121.57M 92.59M
Shares Outstanding (Diluted)
129.17M 129.17M 126.62M 125.77M 125.73M 125.32M 125.3M 125.79M 126.62M 126.62M 126.62M 126.62M 126.62M 126.62M 126.54M 126.54M 121.57M 92.59M
EPS (Basic)
-0.07 -0.05 -0.05 -0.06 -0.05 -0.05 -0.06 -0.05 -0.08 -0.04 -0.05 -0.06 -0.05 -0.04 -0.04 -0.04 -0.06 -0.04
EPS (Diluted)
-0.07 -0.05 -0.05 -0.06 -0.05 -0.05 -0.06 -0.05 -0.08 -0.04 -0.05 -0.06 -0.05 -0.04 -0.04 -0.04 -0.06 -0.04
EBITDA
-8.42M -6.71M -7.15M -6.38M -7.1M -6.97M -9.01M -7.46M -7.79M -7.09M -8.14M -8.2M -6.59M -4.75M -4.83M -5.15M -7M -3.52M
EBIT
-8.42M -6.72M -7.15M -6.38M -7.11M -6.98M -9.02M -7.47M -7.79M -7.1M -8.14M -8.21M -6.59M -4.75M -4.83M -5.16M -7M -3.53M
Depreciation & Amortization
4K 4K 4K 4K 4K 5K 14K 3K 3K 3K 2K 2K 2K 2K 1.74K 6.22K 5.79K 9.26K